HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Thomas Stranzl Selected Research
Thomas Stranzl Research Topics
Disease
4
Hypersensitivity (Allergy)
12/2023 - 04/2017
2
Conjunctivitis
05/2024 - 02/2024
2
Asthma (Bronchial Asthma)
12/2023 - 04/2017
2
Neoplasms (Cancer)
01/2012 - 03/2003
2
Breast Neoplasms (Breast Cancer)
09/2003 - 03/2003
1
Allergic Rhinitis
02/2024
1
Neoplasm Metastasis (Metastasis)
09/2003
1
Multiple Myeloma
02/2003
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2002
1
Lymphoma (Lymphomas)
03/2002
Drug/Important Bio-Agent (IBA)
5
Tablets
IBA
05/2024 - 01/2021
3
Proteins (Proteins, Gene)
FDA Link
04/2017 - 09/2003
2
Immunoglobulin E (IgE)
IBA
12/2023 - 01/2021
2
Allergens
IBA
12/2023 - 04/2017
2
Pyridinolcarbamate (P23)
IBA
01/2021 - 01/2021
2
Cyclin D3
IBA
03/2003 - 03/2002
1
Tryptases (Tryptase)
IBA
12/2023
1
Biomarkers (Surrogate Marker)
IBA
12/2023
1
Eosinophil Cationic Protein
IBA
12/2023
1
Epitopes
IBA
01/2012
1
Messenger RNA (mRNA)
IBA
01/2012
1
Histocompatibility Antigens Class I
IBA
01/2012
1
Amino Acids
FDA Link
01/2012
1
Peptides (Polypeptides)
IBA
01/2012
1
major vault protein
IBA
09/2003
1
Member 1 Subfamily B ATP Binding Cassette Transporter
IBA
09/2003
1
multidrug resistance-associated protein 1
IBA
09/2003
1
Progesterone Receptors (Progesterone Receptor)
IBA
03/2003
1
Estrogen Receptors
IBA
03/2003
1
Cell Cycle Proteins
IBA
03/2003
Therapy/Procedure
3
Immunotherapy
12/2023 - 01/2021
3
Drug Therapy (Chemotherapy)
09/2003 - 02/2003
1
Combination Drug Therapy (Combination Chemotherapy)
03/2002